Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,61475,Aia2,Adjuvant induced arthritis QTL 2,5.8,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,37685175,73066691,Rat,n/a,region,qtl 1000,2313401,Anxrr27,Anxiety related response QTL 27,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),4,33637803,61708341,Rat,n/a,region,qtl 1000,6478724,Anxrr35,Anxiety related response QTL 35,,0.00449,defecation behavior trait (VT:0010462),defecation measurement (CMO:0000997),4,8052189,53052189,Rat,n/a,region,qtl 1000,6478766,Anxrr47,Anxiety related response QTL 47,,0.09637,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,8052189,53052189,Rat,n/a,region,qtl 1000,6478769,Anxrr48,Anxiety related response QTL 48,,0.02514,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,8052189,53052189,Rat,n/a,region,qtl 1000,12798520,Anxrr55,Anxiety related response QTL 55,4.45,0.01,locomotor behavior trait (VT:0001392),number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715),4,29549895,112807890,Rat,n/a,region,qtl 1000,1578655,Bmd11,Bone mineral density QTL 11,11,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),4,24631874,69631874,Rat,n/a,region,qtl 1000,2303168,Bp330,Blood pressure QTL 330,4.25,0.017,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,3043231,145254791,Rat,n/a,region,qtl 1000,10755501,Bp390,Blood pressure QTL 390,2.5,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),4,23850384,169318094,Rat,n/a,region,qtl 1000,619616,Bp79,Blood pressure QTL 79,,0.0292,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,3043231,79575658,Rat,n/a,region,qtl 1000,6893678,Bw108,Body weight QTL 108,2.6,0.006,body mass (VT:0001259),body weight (CMO:0000012),4,42415777,87415777,Rat,n/a,region,qtl 1000,8552801,Bw143,Body weight QTL 143,7.3,,body mass (VT:0001259),ratio of change in body weight to total body weight (CMO:0002216),4,31825560,83531021,Rat,n/a,region,qtl 1000,8694374,Bw155,Body weight QTL 155,3.39,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),4,8052189,53052189,Rat,n/a,region,qtl 1000,8694439,Bw168,Body weight QTL 168,9.57,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),4,39208247,84208247,Rat,n/a,region,qtl 1000,2303585,Bw86,Body weight QTL 86,4,,body mass (VT:0001259),body weight (CMO:0000012),4,12638974,57638974,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,43414605,155469929,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,43414792,146942075,Rat,n/a,region,qtl 1000,2312567,Glom19,Glomerulus QTL 19,1.9,0.006,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),4,49906054,145611886,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,7850904,182171018,Rat,n/a,region,qtl 1000,1300139,Hrtrt6,Heart rate QTL 6,2.85,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,37703272,115372927,Rat,n/a,region,qtl 1000,6909122,Insul22,Insulin level QTL 22,4.63,,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),4,23991721,76238799,Rat,n/a,region,qtl 1000,8655961,Kidm43,Kidney mass QTL 43,18,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),4,34277932,99067150,Rat,n/a,region,qtl 1000,11530004,Niddm71,Non-insulin dependent diabetes mellitus QTL 71,,0.001,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),4,31554484,51311866,Rat,n/a,region,qtl 1000,6909128,Pancm4,Pancreatic morphology QTL 4,11.35,,pancreas mass (VT:0010144),pancreas wet weight (CMO:0000626),4,23991721,76238799,Rat,n/a,region,qtl 1000,61412,Pia2,Pristane induced arthritis QTL 2,3.9,,joint integrity trait (VT:0010548),post-insult time to onset of experimental arthritis (CMO:0001450),4,18222187,61039065,Rat,n/a,region,qtl 1000,8552906,Pigfal3,Plasma insulin-like growth factor 1 level QTL 3,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),4,8052189,53052189,Rat,n/a,region,qtl 1000,1331807,Rf31,Renal function QTL 31,2.988,,urine potassium amount (VT:0010539),urine potassium level (CMO:0000128),4,37703272,75345433,Rat,n/a,region,qtl 1000,8655906,Rf60,Renal function QTL 60,3.8,,blood creatinine amount (VT:0005328),creatinine clearance (CMO:0000765),4,26654749,81874227,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,43414792,146942075,Rat,n/a,region,qtl 1000,10450818,Scl76,Serum cholesterol level QTL 76,3.6,0.01,blood VLDL cholesterol amount (VT:0005144),blood high density lipoprotein cholesterol level (CMO:0000052),4,47685694,55791834,Rat,n/a,region,qtl 1000,10450821,Scl77,Serum cholesterol level QTL 77,4.1,0.01,blood VLDL cholesterol amount (VT:0005144),blood high density lipoprotein cholesterol level (CMO:0000052),4,47685694,55791834,Rat,n/a,region,qtl 1000,10450825,Scl78,Serum cholesterol level QTL 78,3.7,0.01,blood VLDL cholesterol amount (VT:0005144),blood low density lipoprotein cholesterol level (CMO:0000053),4,47685694,55791834,Rat,n/a,region,qtl 1000,9590304,Scort17,Serum corticosterone level QTL 17,4.96,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,8052189,53052189,Rat,n/a,region,qtl 1000,1358352,Srcrt3,Stress Responsive Cort QTL 3,2.29,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,36615599,145611886,Rat,n/a,region,qtl 1000,1358203,Stl19,Serum triglyceride level QTL 19,2.8,0.002,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),4,3044017,64915903,Rat,n/a,region,qtl 1000,631642,Stl2,Serum triglyceride level QTL 2,3.3,,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),4,3047807,55324857,Rat,n/a,region,qtl 1000,2302371,Stl22,Serum triglyceride level QTL 22,5.15,,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),4,3044017,55791834,Rat,n/a,region,qtl 1000,1298082,Stresp4,Stress response QTL 4,,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),4,46898276,145611886,Rat,n/a,region,qtl 1000,61445,Strs3,Sensitivity to stroke QTL 3,3,,cerebrum integrity trait (VT:0010549),post-insult time to onset of cerebrovascular lesion (CMO:0002343),4,39208222,84208222,Rat,n/a,region,qtl 1000,631261,Tcas3,Tongue tumor susceptibility QTL 3,6.88,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),4,7342404,92484039,Rat,n/a,region,qtl 1000,7387227,Uae40,Urinary albumin excretion QTL 40,2.9,0.0052,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),4,16149941,61149941,Rat,n/a,region,qtl 1000,8552782,Vie1,Viral induced encephalitis QTL 1,26.4,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),4,31825560,83531021,Rat,n/a,region,qtl 1000,8552809,Vie5,Viral induced encephalitis QTL 5,25.3,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),4,31825560,83531021,Rat,n/a,region,qtl